News & Media

DiaMonTech: Successful clinical study confirms breakthrough in the development of non-invasive blood glucose monitoring

Berlin, 21 October 2019

DiaMonTech GmbH, a young and innovative medical technology company based in Berlin, published remarkable results of a clinical study, confirming the accuracy of its non-invasive blood glucose-monitoring technology. In the clinical study, the blood glucose of 100 volunteers was measured using DiaMonTech's laser-based, non-invasive technology and compared to a clinically established invasive reference measurement method. The non-invasive method achieved measurement results with a mean error of only 11 percent, which is otherwise only achieved with (minimally-) invasive devices. The convincing results confirm DiaMonTech's plans to launch a product for diabetics for the non-invasive measurement of blood glucose on the market as early as next year.

"The successful completion of the clinical 'Study 100' is a...

CONTINUE

DiaMonTech selected as one of Europe's best deep tech scaleups at the EIT Digital Challenge 2019

Berlin, 7 October 2019

DiaMonTech GmbH, a young and innovative medical technology company has been nominated by EIT Digital, a leading European player in innovation and entrepreneurial education, as a finalist in its pan-European competition EIT Digital Challenge 2019. The competition focuses on startups in growth stage, so called scaleups, with deep tech products that leverage sophisticated, hard-to-reproduce technologies fueling the digital transformation.

"After winning the 'Start me up!' founder prize by BILANZ magazine in 2017, this is already the second renowned competition in which we have reached the final. In a field of nearly 300 participating start-ups, this is already a great...

CONTINUE

DiaMonTech wins Enrico Just as Managing Director and CFO

Berlin, 1 October 2019

DiaMonTech GmbH, a young and innovative medical technology company, has appointed Enrico Just as an additional Managing Director and CFO of the company. He took office on 1 October.

"We are pleased to have gained Enrico Just as an expert in the development of growth companies. He knows exactly where to start in order to further boost the development of DiaMonTech. We can benefit in particular from his excellent network and his wealth of experience," says Thorsten Lubinski, co-founder and CEO of DiaMonTech GmbH.

"DiaMonTech is a company with great potential and a highly...

CONTINUE

DIAMONTECH: INNOVATIVE, PAIN-FREE BLOOD GLUCOSE MONITORING TO IMPROVE THE QUALITY OF LIFE OF DIABETES PATIENTS IN GERMANY WITH THE HELP OF LOCAL PHARMACIES

BERLIN, 16 SEPTEMBER 2019

Germany's pharmacists want to ease life for millions of diabetics by offering them pain-free blood glucose monitoring without taking blood as soon as possible. The Deutscher Apothekerverband e. V. (DAV; German Association of Pharmacists) and DiaMonTech GmbH, a young and innovative medical technology company, intend a strategic cooperation to significantly improve the care of diabetes patients and to take an innovative step into the future."The Deutscher Apothekerverband is an important partner for ...

CONTINUE

DIAMONTECH SUCCESSFULLY CONCLUDES FINANCING ROUND OF MORE THAN 7 MILLION EURO

BERLIN, 9 SEPTEMBER 2019

DiaMonTech GmbH, a young and innovative medical technology company, has successfully completed its Series A financing round. The company will receive a total of more than 7 million euros. The lead investor for this growth financing is Bioventure, an investor specialized in biotech and life science. In addition, DiaMonTech has gained two family offices as new investors. Existing shareholders - such as IBB Beteiligungsgesellschaft via its fund "VC Fonds Technologie Berlin" - also participated in the financing round.
DiaMonTech's goal is to provide diabetes patients worldwide with a groundbreaking technology for...

CONTINUE

DIAMONTECH'S FIRST PRODUCT "DMT BASE" RECEIVES CE-CERTIFICATION FOR NON-INVASIVE BLOOD GLUCOSE MONITORING WITH LASER-BASED TECHNOLOGY

BERLIN, 22 AUGUST 2019

DiaMonTech GmbH, a young medical technology company, has received the CE certification for its first medical product "DMT Base". The device enables non-invasive blood glucose measurement using laser-based technology. The certification confirms that the patented technology meets the high safety and performance standards for medical devices required for market approval. The label is valid for all...

CONTINUE

DiaMonTech meets Federal Secretary of Health Spahn

Berlin, 26 March 2019

DiaMonTech GmbH, a start-up company specializing in non-invasive blood glucose measurement methods, took part in the "Innovation trifft Politik" forum. At the series of events, which took place at the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), the company introduced itself to Federal Secretary of Health Jens Spahn, among others. The aim of the conference was to...

CONTINUE

DiaMonTech collects 5 million euros

Berlin, 4 September 2018

DiaMonTech GmbH, a start-up specializing in non-invasive blood glucose measurement methods, has successfully completed its second financing round. In total, the company will receive around 5 million euros from old and new investors. The IBB Beteiligungsgesellschaft from Berlin, the Japanese electronics group Macnica and the Chinese venture capitalist Jindong Capital are the largest investors. DiaMonTech intends to use the money to advance...

CONTINUE

DiaMonTech awarded as best start-up 2017

Berlin, 23 June 2017

DiaMonTech GmbH, a start-up company specializing in non-invasive blood glucose measurement methods, was awarded the "Start me up!" prize by the business magazine BILANZ. A total of 243 start-ups participated in the 100,000 euros competition. The 14-member jury was convinced by the innovative and patented method for non-invasive measurement of...

CONTINUE

Media

Life is on!

Stay tuned and get updates.

We are working hard in our lab day and night but it takes some time to develop a new medical device. Subscribe to our newsletter to get the latest news.

Notify me